GlassScriptPhysician profile
Judy B Vire
NPI 1881782357
$530.19
in general payments reported to CMS, 2019-2025
15 companies · $54.72 in 2025
The $54.72 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $146 · 2023: $95.44 · 2024: $82.43 · 2025: $54.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $136.17 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $63.20 | 2022 | |
| Amarin Pharma, INC. | $41.89 | 2021-2022 | |
| Sanofi Pasteur INC. | $39.12 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $35.99 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $32.83 | 2021 | |
| Lilly USA, LLC | $32.01 | 2022-2024 | Mounjaro, Zepbound |
| Tactile Systems Technology INC | $30.03 | 2024 | Entre Plus, Flexitouch Plus |
| Glaxosmithkline, LLC. | $28.08 | 2023 | Shingrix |
| Exact Sciences Corporation | $18.73 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $17.51 | 2024 | Dexcom G6 Transmitter |
| Paratek Pharmaceuticals, INC. | $14.70 | 2024 | Nuzyra |
| Cranial Technologies, INC | $14.31 | 2023 | Doc Band |
| Kowa Pharmaceuticals America, INC. | $13.93 | 2023 | Seglentis |
| Astellas Pharma US INC | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judy Vire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.